Based on this evidence, it is reasonable to suggest that the refractory accumulation of HIF-1α in the nucleus of glioma cells following reoxygenation and subsequent return to hypoxia in our models is at least partly due to an upregulation of PHD2 and PHD3 activity. The gene discussed is EGLN3; the disease is central nervous system cancer.